Your browser doesn't support javascript.
loading
Anti-HER2 Affibody-Conjugated Photosensitizer for Tumor Targeting Photodynamic Therapy.
Li, Shuang; Jin, Yingying; Su, Yao; Li, Wenjing; Xing, Yutong; Wang, Fengwei; Hong, Zhangyong.
Afiliação
  • Li S; State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Protein Sciences, College of Life Sciences, Nankai University, Tianjin 300071, P. R. China.
  • Jin Y; People's Hospital of Tianjin, Tianjin 300180, P. R. China.
  • Su Y; State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Protein Sciences, College of Life Sciences, Nankai University, Tianjin 300071, P. R. China.
  • Li W; State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Protein Sciences, College of Life Sciences, Nankai University, Tianjin 300071, P. R. China.
  • Xing Y; State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Protein Sciences, College of Life Sciences, Nankai University, Tianjin 300071, P. R. China.
  • Wang F; People's Hospital of Tianjin, Tianjin 300180, P. R. China.
  • Hong Z; State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Protein Sciences, College of Life Sciences, Nankai University, Tianjin 300071, P. R. China.
Mol Pharm ; 17(5): 1546-1557, 2020 05 04.
Article em En | MEDLINE | ID: mdl-32267710

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fotoquimioterapia / Fármacos Fotossensibilizantes / Receptor ErbB-2 / Anticorpos / Neoplasias Experimentais Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fotoquimioterapia / Fármacos Fotossensibilizantes / Receptor ErbB-2 / Anticorpos / Neoplasias Experimentais Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article